1. Wang S, Ding YB, Chen GY, Xia JG, Wu ZY. Hypermethylation of Syk gene in promoter region associated with oncogenesis and metastasis of gastric carcinoma. World J Gastroenterol, 2004, 10(12), 1815-18182. Ling LJ, Wang S*, Liu XA, Shen EC, Ding Q, Lu C, Xu J, Cao QH, Zhu HQ, Wang F. A novel mouse model of human breast cancer stem-like cells with high CD44+CD24- /lower phenotype metastasis to human bone. Chin Med J (Engl), 2008, 121(20), 1980-19863. Ding Q, Yang LX, Yang HW, Jiang C, Wang YF, Wang S*. Cytotoxic and antibacterial triterpenoids derivatives from Clematis ganpiniana. .J Ethnopharmacol, 2009, 126(3), 382-3854. Wang J, Xia TS, Liu XA, Ding Q, Du Q, Yin H, Wang S*. A novel orthotopic and metastatic mouse model of breast cancer in human mammary microenvironment. Breast Cancer Res Treat, 2010, 120(2), 337-3445. Xia TS, Wang J, Yin H, Ding Q, Zhang YF, Yang HW, Liu XA, Dong M, Du Q, Ling LJ, Zha XM, Fu W, Wang S*.Human tissue-specific microenvironment: an essential requirement for mouse models of breast cancer. Oncol Rep, 2010, 24(1), . Liu X, Wang Z, Yu J, Lei G, Wang S*. Three polymorphisms in interleukin-1beta gene and risk for breast cancer: a meta-analysis Breast Cancer Res Treat, 2010, 124(3), 821-8257. Zhu J, Meng X, Yan F, Qin C, Wang M, Ding Q, Li P, Yang J, Ju X, Zhang Z, Wang S*, Yin C. A functional epidermal growth factor (EGF) polymorphism, EGF serum levels and renal cell carcinoma risk in a Chinese population. J Hum Genet, 2010, 55(4), 236-2408. Ling LJ, Lu C, Zhou GP, Wang S*. Ectopic expression of RhoBTB2 inhibits migration and invasion of human breast cancer cells. Cancer Biol Ther, 2010, 10(11), 1115-11229. Zhou WB, Yin H, Liu XA, Zha XM, Chen L, Dai JC, Tao AD, Chen L, Ma JJ, Ling LJ, Wang S*. Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients. BMC Cancer, 2010, 10, 28110. Zou J, Zhang X, Yang H, Zhu Y, Ma H, Wang S*. Rapamycin-loaded nanoparticles for inhibition of neointimal hyperplasia in experimental vein grafts. Ann Vasc Surg, 2011, 25(4), 538-54611. Zhou WB, Ding Q, Chen L, Liu XA, Wang S*. Toremifene is an effective and safe alternative to tamoxifen in adjuvant endocrine therapy for breast cancer: results of four randomized trials. Breast Cancer Res Treat, 2011, 128(3), 625-63112. Zhou WB, Liu XA, Dai JC, Wang S*. Meta-analysis of sentinel lymph node biopsy at the time of prophylactic mastectomy of the breast. Can J Surg, 2011, 54(5), . Zhou WB, Xue DQ, Liu XA, Ding Q, Wang S*. The influence of family history and histological stratification on breast cancer risk in women with benign breast disease: a meta-analysisJ Cancer Res Clin Oncol, 2011, 137(7), 1053-106014. Ni XJ, Xia TS, Zhao YC, Ma JJ, Zhao J, Liu XA, Ding Q, Zha XM, Wang S*. Postmenopausal hormone therapy is associated with in situ breast cancer risk Asian Pac J Cancer Prev, 2012, 13(8), 3917-392515. Wang M, Zhou W, Zhao Y, Xia T, Zha X, Ding Q, Liu X, Zhao Y, Ling L, Chen L, Wang S*.A novel finding of sentinel lymphatic channels in early stage breast cancer patients: which may influence detection rate and false-negative rate of sentinel lymph node biopsy. PLoS One, 2012, 7(12), . Chen L, Zhou WB, Zhao Y, Liu XA, Ding Q, Zha XM, Wang S*. Cancer/testis antigen SSX2 enhances invasiveness in MCF-7 cells by repressing ERalpha signaling Int J Oncol, 2012, 40(6), 1986-199417. Zhou W, Zha X, Liu X, Ding Q, Chen L, Ni Y, Zhang Y, Xu Y, Chen L, Zhao Y, Wang S*. US-guided percutaneous microwave coagulation of small breast cancers: a clinical study. Radiology, 2012, 263(2), . Wang X, Wang G, Zhao Y, Liu X, Ding Q, Shi J, Ding Y, Wang S*. STAT3 mediates resistance of CD44(+)CD24(-/low) breast cancer stem cells to tamoxifen in vitro. Biomed Res, 2012, 26(5), 325-33519. Xu L, Ju XB, Li P, Wang J, Shi ZM, Zheng MJ, Xue DD, Xu YJ, Yin YM, Wang S*, You YP. Association between the Ku70-1310C/G promoter polymorphism and cancer risk:a meta-analysis. Asian Pac J Cancer Prev, 2012, 13(2), 683-68720. Zhao YC, Ni XJ, Wang MH, Zha XM, Zhao Y, Wang S*. Tumor-derived VEGF-C, but not VEGF-D, promotes sentinel lymph node lymphangiogenesis prior to metastasis in breast cancer patients. Med Oncol, 2012, 29(4), 2594-260021. Zhou W, He Z, Xue J, Wang M, Zha X, Ling L, Chen L, Wang S*, Liu X. Molecular subtype classification is a determinant of non-sentinel lymph node metastasis in breast cancer patients with positive sentinel lymph nodes. PLoS One, 2012, 7(4), e3588122. Zhou W, Ding Q, Liang X, He Z, Zha X, Liu X, Wang S*. The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy. PLoS One, 2012, 7(5), e3724923. Zhou W, Ding Q, Liu X, Jiang Y, Chen L, Zhang Y, Xia T, Wang S*. Percutaneous microwave coagulation for eradication of VX2 tumors subcutaneously in rabbits. World J Surg Oncol, 2012, 10, 9724. Zheng MJ, Wang J, Chen YW, Xu L, Xue DD, Fu W, Zhang YF, Du Q, Zhao Y, Ling LJ, Ding Q, Liu XA, Zha XM, Zheng W, Xia TS, Wang S*.A novel mouse model of gastric cancer with human gastric microenvironment Cancer Lett, 2012, 325(1), 108-11525. Liu X, Qin Z, Shen H, Xue J, Jiang Y, Hu Z, Shen H, Wang S*. Genetic variants at 5p12 and risk of breast cancer in Han Chinese. J Hum Genet, 2012, 57(10), 638-64126. Xia TS, Shi JP, Ding Q, Liu XA, Zhao Y, Liu YX, Xia JG, Wang S*, Ding YB. Reactivation of Syk gene by AZA suppresses metastasis but not proliferation of breast cancer cells. Med Oncol, 2012, 29(2), 448-45327. Chen L, Zhou WB, Zhao Y, Liu XA, Ding Q, Zha XM, Wang S*. Bloody nipple discharge is a predictor of breast cancer risk: a meta-analysis. Breast Cancer Res Treat, 2012, 132(1), 9-1428. Cui YY, Qian JM, Yao AH, Ma ZY, Qian XF, Zha XM, Zhao Y, Ding Q, Zhao J, Wang S*, Wu J. SOD mimetic improves the function, growth, and survival of small-size liver grafts after transplantation in rats. Transplantation, 2012, 94(7), 687-69429. Xia TS, Wang GZ, Ding Q, Liu XA, Zhou WB, Zhang YF, Zha XM, Du Q, Ni XJ, Wang J, Miao SY, Wang S*. Bone metastasis in a novel breast cancer mouse model containing human breast and human bone. Breast Cancer Res Treat, 2012, 132(2), 471-48630. Ni X, Ma J, Zhao Y, Wang Y, Wang S*. Meta-analysis on the association between non-steroidal anti-inflammatory drug use and ovarian cancer. Br J Clin Pharmacol, 2013, 75(1), 26-3531. Pan H, Xia K, Zhou W, Xue J, Liang X, Cheng L, Wu N, Liang M, Wu D, Ling L, Ding Q, Chen L, Zha X, Liu X, Wang S*. Low serum creatine kinase levels in breast cancer patients: a case-control study. PLoS One, 2013, 8(4), e6211232. Zhou W, Pan H, Liang M, Xia K, Liang X, Xue J, Cheng L, Xue J, Chen S, Liu X, Ding Q, Ling L, Wang S*. Family history and risk of ductal carcinoma in situ and triple negative breast cancer in a Han Chinese population: a case-control study. World J Surg Oncol, 2013, 11, 24833. Ni X, Zhao Y, Ma J, Xia T, Liu X, Ding Q, Zha X, Wang S*. Hypoxia-induced factor-1 alpha upregulates vascular endothelial growth factor C to promote lymphangiogenesis and angiogenesis in breast cancer patients. J Biomed Res, 2013, 27(6), 478-48534. Zhou W, Liang M, Pan H, Liu X, Jiang Y, Wang Y, Ling L, Ding Q, Wang S*. Comparison of ablation zones among different tissues using 2450-MHz cooled-shaft microwave antenna: results in ex vivo porcine models. PLoS One, 2013, 8(8), e7187335. Zhou W, Liu X, Ding Q, Zha X, Wang S*. Long-term outcomes of breast cancer ablationRadiology, 2013, 269(1), 309-31036. Zhou W, Ding Q, Pan H, Wu N, Liang M, Huang Y, Chen L, Zha X, Liu X, Wang S*. Risk of breast cancer and family history of other cancers in first-degree relatives in Chinese women: a case control study. BMC Cancer, 2014, 14, 66237. Ni X, Xia T, Zhao Y, Zhou W, Wu N, Liu X, Ding Q, Zha X, Sha J, Wang S*. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2. Cancer Sci, 2014, 105(1), 18-2538. Miao SY, Zhou W, Chen L, Wang S*, Liu XA. Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244,768 controls. Asia Pac J Clin Oncol, 2014, 10(2), 101-10839. Yang T, Xu F, Zhao Y, Wang S*, Yang M, Chen Y. A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer. Proteomics Clin Appl, 2014, 8(9-10), 773-78240. Ren Y, Han X, Yu K, Sun S, Zhen L, Li Z, Wang S*. microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells. Mol Med Rep, 2014, 10(1), 315-32141. Chen J, Jiang P, Wang HJ, Zhang JY, Xu Y, Guo MH, Zhang B, Tang CY, Cao HY, Wang S*. The efficacy of molecular subtyping in predicting postoperative recurrence in breast-conserving therapy: a 15-study meta-analysis. World J Surg Oncol, 2014, 12, 21242. Zhou W, Jiang Y, Chen L, Ling L, Liang M, Pan H, Wang S, Ding Q, Liu X, Wang S*. Image and pathological changes after microwave ablation of breast cancer: a pilot study. Eur J Radiol, 2014, 83(10), 1771-177743. 王水，张保康，赵同生, Hassab 手术后肝硬变大鼠动脉血酮体比改变的意义, 南京医学院学报, 1991, (04), 302-30544. 王水，刘训良，陆辉，孔连宝, B 型 Niemann-Pick 病脾脏切除一例, 南京医学院学报, 1993, (02), 18645. 王水，沈亚勋, 老年原发性胆囊癌误诊 27 例分析, 南京医科大学学报, 1997, (02), 7746. 王水，查小明，武正炎, 原发性甲状旁腺机能亢进症术后低钙血症及其处理, 江苏医药, 2001, (03), 18047. 王水，查小明, 三苯氧胺对绝经后乳腺癌患者子宫和卵巢的影响, 南京医科大学学报, 2001, (04), 320-32148. 王水，林红军，查小明, 三苯氧胺对乳腺癌患者子宫卵巢的影响, 中国肿瘤临床, 2001, (05), 389-39049. 王水，武正炎，范萍，查小明, 血管内皮细胞生长因子在乳腺癌组织中的表达及其生物学意义, 南京医科大学学报, 2001, (06), 503-50550. 王水，查小明，范萍，武正炎, 乳腺癌染料法前哨淋巴结活检的临床意义, 中华肿瘤杂志, 2002, (02), 9051. 王水，刘晓，刘晓安，查小明，符德元，甄林林，范萍，武正炎，乳腺癌前哨淋巴结活检染料和手术时机选择，肿瘤学杂志, 2002, (06), 332-33552. 王水，刘晓安，武正炎，影响染料法乳腺癌前哨淋巴结活检成功率的一些因素外科理论与实践, 2004, (02), 107-10953. 王水，范萍，武正炎，乳腺癌前哨淋巴结淋巴细胞亚群的初步研究，中华肿瘤杂志, 2004, (04), 31-3354. 王水，刘晓安，赵燕超，武正炎，采用异硫蓝和美蓝行乳腺癌前哨淋巴结活检的临床价值，江苏医药, 2004, (07), 506-50755. 王水，范萍，刘晓安，武正炎，乳腺癌骨髓和前哨淋巴结微小转移检测的临床研究，中华普通外科杂志, 2004, (09), 54-5556. 耿强，王水，范萍，刘晓安，郑伟，乳腺癌前哨淋巴结和骨髓和外周血微小转移的联合检测，肿瘤防治杂志, 2005, (02), 85-8857. 徐鲲，刘晓安，王水，张小林，陆辉，乳腺癌前哨淋巴结活检染料选择的实验研究，南京医科大学学报(自然科学版), 2005, (03), 201-20358. 徐鲲，刘晓安，王水，王振中，乳腺癌前哨淋巴结活检常用染料效果实验研究，现代肿瘤医学, 2005, (04), 433-43559. 徐鲲，刘晓安，王水，周青，耿强，中华墨汁作为乳腺癌前哨淋巴结活检示踪剂的实验研究，肿瘤防治杂志, 2005, (05), 321-32460.王水，刘晓安，早期乳腺癌治疗中前哨淋巴结活检应用价值探讨，中国实用外科杂志, 2006, (04), 312-31461. 王水，赵佳，刘晓，甲状腺炎合并甲状腺功能亢进的手术治疗，中国实用外科杂志, 2006, (07), 503-50562. 王水，刘晓安，赵佳，耿强，刘力嘉，染料法乳腺癌前哨淋巴通道的研究，中华外科杂志, 2006, (11), 748-75063. 曹勤洪，王水，徐鲲 ，刘晓安，刘力嘉，中华墨汁作为前哨淋巴结活检新型示踪剂的实验研究，The Chinese-German Journal of Clinical Oncology, 2006, (01), 36-3964. 郝汉霞，王水，刘力嘉，范萍，杜青，张伟民，王聪， 乳腺癌肿瘤相关巨噬细胞中 HIF-2α/EPAS1 表达与血管生成的关系，中华肿瘤防治杂志, 2006, (03), 169-17265. 王锋，王水，陆辉，郑伟，孙琳， 乳腺癌组织中 p21~(WAF1)、CDK4 的表达及临床意义，江苏医药, 2006, (06), 520-52266. 赵佳，刘晓安，王水，刘力嘉 免疫组织化学和RT-PCR法检测乳腺癌骨髓和前哨淋巴结微小转移的临床研究现代肿瘤医学, 2006, (07), 813-81667. 邹汉青，王水，林红军，张智弘，刘晓安，彭晓静， 活体兔肌肉组织微波固化后病理学变化的实验研究 中华肿瘤防治杂志, 2006, (07), 489-49168. 凌立君，魏惠华，曾莉，刘晓安，王凤良，赵佳，贾晓斌，王水，盐酸川芎嗪微囊的制备及质量控制，中成药, 2006, (11), 1692-169369. 赵佳，王水，刘晓安，刘力嘉，IHC 和 PCR 法联合检测乳腺癌前哨淋巴结的微转移，中华肿瘤防治杂志, 2006, (16), 1229-123170. 王水，刘晓安，赵佳，耿强，刘力嘉，联合法观察前哨淋巴通道的临床研究，中华乳腺病杂志(电子版), 2007, (01), 35-3871. 王锋，王水，宣卓琦，孙琳，陆辉，乳腺癌细胞中 p53、C-erbB-2、p21~(WAF1)和 CDK4 的表达及临床意义， 南京医科大学学报(自然科学版), 2007, (01), 70-7372. 凌立君，赵佳，王水，刘晓安，核素法前哨淋巴通道的研究，中华乳腺病杂志(电子版), 2007, (02), 16-1873. 王锋，夏添松，夏建国，陈国玉，王水胃肠道间质肿瘤伴肝转移 18 例临床分析，临床肿瘤学杂志, 2007, (03), 191-19374. 许健，王水，许立生，杜青，刘晓安，乳腺癌细胞系中肿瘤干细胞相关亚群初步研究，南京医科大学学报(自然科学版), 2007, (04), 350-35575. 谢锡驹，王水，郑伟，查小明，乳腺癌患者血清 IGF-Ⅱ水平及其在肿瘤组织中的表达，江苏医药, 2007, (07), 672-67476. 王凤良，凌立君，沈恩超，刘晓安，王水，血清 Tracp5b 诊断乳腺癌骨转移的临床价值，南京医科大学学报(自然科学版), 2007, (07), 702-70577. 许健; 王水;许立生，杜青，刘晓安，赵佳，雌激素对 MCF-7 中肿瘤干细胞相关亚群影响的实验研究，中华肿瘤防治杂志, 2007, (09), 650-65278. 陈龙舟，赵佳，王凤良，凌立君，刘晓安，王水 淋巴结阴性乳腺癌骨髓微小转移联合检测的临床研究，南京医科大学学报(自然科学版), 2007, (09), 939-94279. 许立生，王水，许健，杜青，无血清悬浮法培养MCF-7细胞系并筛选该细胞系中肿瘤干细胞相关亚群的初步研究，中华肿瘤防治杂志, 2007, (10), 736-74080. 谢晖，曹勤洪，夏锴，刘晓安，王水乳腺癌组织 APRG1 基因表达的初步研究，江苏医药, 2007, (10), 1006-100881. 刘月仙，夏添松，李俊芳，王水，共刺激分子 B7-2 基因转染抑制乳腺癌生长和转移的实验研究，南京医科大学学报(自然科学版), 2007, (11), 1228-123282. 孙蓉，凌立君，刘晓安，赵佳，耿强，王水，联合法前哨淋巴通道的临床研究，中华肿瘤防治杂志, 2007, (17), 1328-133083. 王凤良，王水，凌立君，沈恩超，刘晓安，血清 Tracp5b 诊断乳腺癌骨转移及评价双膦酸盐治疗疗效的临床意义，中华肿瘤防治杂志, 2007, (21), 1628-163184. 王水，赵佳，乳腺癌前哨淋巴结活检的研究进展，中华普外科手术学杂志(电子版), 2008, (02), 147-15285. 王水，赵佳，早期乳腺癌前哨淋巴结活检术的进展，中华乳腺病杂志(电子版), 2008, (03), 255-26186. 王水，重视老年甲状腺疾病诊断与治疗，实用老年医学, 2008, (04), 243-24487. 李昌文，刘晓安，林红军，章宜芬，王水冷循环微波固化家猪乳腺实验研，南京医科大学学报(自然科学版), 2008, (01), 16-1988. 沈恩超，凌立君，王水，刘晓安，朱海清，李凤山，SDF-1、CXCR4 在乳腺癌组织及转移淋巴结中的表达及其意义，江苏医药, 2008, (04), 367-36989. 钱超，夏锴，张静静，杜青，刘晓安，王水缺氧条件下雷帕霉素抗人乳腺癌 MCF-7 细胞增殖作用的研究，南京医科大学学报(自然科学版), 2008, (06), 742-74690. 高泽俊，袁小青，沈捷，马向华，王水，MAPKs通路在Leptin促人乳腺癌细胞系增殖中的机制研究，南京医科大学学报(自然科学版), 2008, (11), 1410-141491.刘学敏，王水，夏添松，王珏，刘晓安 慢病毒转染绿色荧光蛋白对乳腺癌细胞系肿瘤干细胞相关亚群的影响， 中国组织工程研究与临床康复, 2008, (38), 7507-751092.王水，乳管镜技术临床应用及其诊疗价值，中国实用外科杂志, 2009, (03), 261-26393. 顾则娟，王水，张镇静，王荣，谢晓峰，朱琳，戴晓冬，叶桂华，林征，方小平， 殷蓉，舒心病房护理运行模式的建立与应用，中华护理杂志, 2009, (10), 929-93194. 宋兵，沈历宗，徐皓，黄华兴，肇毅，史京萍，王水外科实习生出科量化考核结果的研究分析与思考，临床和实验医学杂志, 2010, (05), 353-35595. 傅卫，王水，杜青，肇毅，查小明，刘晓安，巢式 RT-PCR 检测乳腺癌外周血循环肿瘤细胞的临床价值，南京医科大学学报(自然科学版), 2010, (06), 818-82196. 蒋超，丁强，王水，杨海伟，张炜明，FISH 检测乳腺癌石蜡组织切片的酶消化时间的探究，现代生物医学进展, 2010, (15), 2907-290997. 陈翔，王水，乳腺癌前哨淋巴结活检研究现状及进展，中国普外基础与临床杂志, 2011, (01), 98-10298. 黄华兴，沈历宗，肇毅，凌立君，史京萍，徐皓，吴蔚，王水，PBL与LBL相结合在基础外科学实践教学中的应用，南京医科大学学报(社会科学版), 2011, (03), 227-22999. 崔一尧，王水，临床推广乳腺癌前哨淋巴结活检技术的影响因素分析，中国医学伦理学, 2011, (05), 611-613100. 黄华兴，沈历宗，肇毅，凌立君，史京萍，徐皓，吴蔚，王水，外科学基础考试模式的改革与探讨，南京医科大学学报(社会科学版), 2011, (06), 488-490101. 崔一尧，王水，前哨淋巴结活检在乳腺癌治疗中的意义，医学与哲学(临床决策论坛版), 2011, (08), 41-42102. 史京萍，夏添松，丁强，刘晓安，査小明，王水，CpG 寡核苷酸促进 Toll 样受体 9 的表达增强乳腺癌细胞侵袭南京医科大学学报(自然科学版), 2011, (08), 1161-1163103. 崇梅红，王水，乳腺癌血行微小转移研究进展，中华临床医师杂志(电子版), 2011, (10), 2970-2974104. 崇梅红，王水，乳腺癌淋巴结微小转移研究进展，中华临床医师杂志(电子版), 2011, (11), 3254-3257105. 许立生，王水，黄中晶，沈恩超，钱超，人生长激素对乳腺癌细胞增殖和凋亡的影响，天津医药, 2011, (12), 1141-1143106. 马晶晶，王水，郑明洁，缪苏宇，徐露，王珏，乳腺癌细胞株两种原代培养方法的比较，江苏医药, 2011, (16), 1865-1867107. 刘钊，王水，孕激素及雌激素对乳腺癌细胞 RANKL 及其受体的调节作用，江苏医药, 2011, (16), 1874-1876108. 许立生，王水，黄中晶，沈恩超，钱超，CD44~+/CD24~(-/low)/ABCG2~-乳腺癌干细胞与临床治疗及预后的关系，实用医学杂志, 2011, (21), 3877-3879109. 崇梅红，王水，查小明，刘晓安，凌立君，肇毅，实时荧光定量PCR法检测乳腺癌外周血循环肿瘤细胞的临床价值，南京医科大学学报(自然科学版), 2012, (02), 220-225110. 赵奕华，李鑫，王水，王虹，公立医院改革背景下医用耗材管理的困难与对策，中国医疗设备, 2012, (11), 100-102111.周茜，王水，钱宁，刘小丰，陆澄，骨桥蛋白在乳腺癌组织中的表达及其与临床病理和 p53 的关系，江苏医药, 2012, (20), 2387-2389112. 许立生，王水，黄中晶，赵志泓，沈恩超，钱超，ER、PR、VEGF、CA15-3、CA125 和 CEA 水平在乳腺癌预后判断中的临床意义，实用医学杂志, 2012, (21), 3565-3567113. 张桂普，王水，郑明洁，王珏，“人源性”乳腺微环境促进人源性乳腺癌细胞发生上皮细胞间充质转化，江苏医药, 2012, (22), 2652-2654114. 王水，刘钊，乳腺神经内分泌癌，中国实用外科杂志, 2013, (03), 238-240115. 姚秀蕾，肇毅，姚志勇，王水，超声引导粗针活检在触诊阴性乳腺肿瘤诊断中的临床意义，中国医药导报, 2013, (02), 41-43116. 黄华兴，张永杰，沈历宗，肇毅，王水，整合外科与解剖教学,架构临床与基础桥梁，南京医科大学学报(社会科学版), 2013, (03), 273-275117.周悦，黄华兴，骆金华，陈亮，王水，胸腔镜技术应用以提高胸心外科教学效果的研究与实践，南京医科大学学报(社会科学版), 2013, (05), 472-473118. 杨小冬，黄华兴，黄平，沈历宗，王水，浅谈外科学基础实践教学师资的选拔与培养，南京医科大学学报(社会科学版), 2013, (06), 564-566119. 朱倩男，夏添松，凌立君，王水，乳腺癌术后上肢淋巴水肿发生机制及预防进展，中华乳腺病杂志(电子版), 2013, (06), 442-445120. 王若曦，王水，乳腺癌 ER、PR 及 HER-2 在原发灶和转移灶之间表达关系的研究进展，江苏医药, 2013, (08), 958-961121.吴丹，刘晓安，查小明，王水，乳腺淋巴瘤 12 例临床分析，江苏医药, 2013, (14), 1660-1662122.吴蔚，沈历宗，肇毅，凌立君，史京萍，黄华兴，王水，积极心理学在外科学总论实验教学中的应用，中国医学创新, 2013, (34), 141-142123.徐海萍，王娟，孙杰，王珏，王水，查小明，鲁婷婷，孙茹萍，杨晓文，优化乳腺癌健康宣教的探讨，江苏医药, 2014, (05), 604-606
专业领域：乳腺癌杂志国家：美国投稿系统：是否收版面费：是分享的经验或教训：1、投稿20天左右可以发信问一问，我投的时候用了差不多一个晚上，网络太拥挤太慢。所以误以为结束了，但是实际上没有递交成功。白白的耽误了两个月。我的催问信 ，供参考：Dear Dr. Lewis A Chodosh ，（该杂志主编）We submitted a paper entitled " *** " (Manuscript ID: 5340265452290289) on October 15, 2008. About 50 days has past, but the manuscript is still under review. I am quite anxious for the current status regarding our paper. And how long dose the review progress last, usually?When can we receive your decision letter?Looking forward to yours reply!Kind sincerely,***2、投这个杂志主要是身边有师兄投了，而且中了。该杂志偏重于临床，乳腺癌患者或荷瘤动物研究，可能比细胞系研究有优势。当然文章要有新意，那就不必说了。3、杂志的速度不算太快。你若急着赶时间，建议稿投其他速度快的杂志。
分类: 教育/科学 >> 外语学习 问题描述: Do you think our life is full of causes of cancer?why? 200-300词左右，请多举例，谢谢！ 解析: I think there are many of ways that can cause cancer in our daily life. Cancer has many causesThere are about 200 different types of cancer affecting all the different body tissues. What affects one body tissue may not affect another. For example, tobacco *** oke that you breathe in may help to cause lung cancer. Over exposing your skin to the sun could give you a melanoma on your leg. But the sun won't give you lung cancer and *** oking won't give you melanoma. Apart from infectious diseases, most illnesses are 'multifactorial'. Cancer is no exception. Multifactorial means that there are many factors involved. In other words, there is no single cause for any one type of cancer. Carcinogens A 'carcinogen' is something that can help to cause cancer. Tobacco *** oke is a powerful carcinogen. But not everyone who *** okes gets lung cancer. So there must be other factors at work. Age Most types of cancer bee more mon as we get older. This is because the changes that cause a cell to bee cancerous in the first place take a long time to develop. There have to be a number of changes to the genes within a cell before it turns into a cancer cell. The changes can happen by accident when the cell is dividing. Or they can happen because the cell has been damaged by carcinogens and the damage is then passed on to future 'daughter' cells when that cell divides. The longer we live, the more time there is for us to accumulate these geic mistakes in our cells. Geic make up There have to be a number of geic mutations within a cell before it bees cancerous. Sometimes we are born with one of these mutations already. This does not mean we will get cancer. But with one mutation from the outset, it makes it more likely statistically that we will. Doctors call this 'geic predisposition'. The BRCA1 and BRCA2 breast cancer genes are examples of geic predisposition. Women who carry one of these faulty genes have a higher chance of developing breast cancer than women who do not. The BRCA genes are good examples for another reason. Most women with breast cancer do not have a mutated BRCA1 or BRCA 2 gene. Less than 5% of all breast cancer is due to these genes. So although women with one of these genes are individually more likely to get breast cancer, most breast cancer is not caused by a high risk inherited gene fault. This is true of other mon cancers where some people have a geic predisposition, for example colon (large bowel) cancer. Researchers are looking at the genes of people with cancer in a study called SEARCH. They also hope to find out more about how other factors might interact with genes to increase the risk of cancer. Information about this study is on our clinical trials database. Either follow the link or click on the blue button to the left of any CancerHelp UK screen. Then type SEARCH into the Free Text Search box. Please note that you cannot volunteer for this study. The immune system People who have problems with their immune systems are more likely to get some forms of cancer. This group includes people who Have had an transplants and take drugs to suppress their immune systems to stop an rejection Have AIDS Are born with rare medical syndromes which affect their immunity The kinds of extra cancers that affect these groups of people fall into o, overlapping groups Cancers that are caused by viruses, such as cervical cancer or some lymphomas Lymphomas Chronic infections or transplanted ans can continually stimulate cells to divide. This continual cell division means that immune cells are more likely to acquire mutations and develop into lymphomas. Diet Cancer experts estimate that changes to our diet could prevent about one in three cancer deaths in the UK. In the western world, many of us eat too many animal fats and not enough fresh fruit and vegetables. This type of diet is known to increase your risk of cancer. But how exactly we should alter our diets is not clear. There is more about this in the page on diet causing cancer. Sometimes foods or food additives are blamed for directly causing cancer and described as 'carcinogenic'. This is often a distortion of the truth. Sometimes a food is found to contain a substance that can cause cancer but in such *** all amounts that we could never eat enough of it to do any harm. And some additives may actually protect us. There is more about food additives in the page on diet causing cancer. Day to day environment By this we mean what is around you each day that may help to cause cancer. This could include Tobacco *** oke The sun Natural and man made radiation Work place hazards A *** estos Some of these are avoidable and some aren't. Most are only contributing factors to causing cancers - part of the jigsaw puzzle that scientists are still trying to put together. There is more about this in the page on causes of cancer in the environment . Viruses Viruses can help to cause some cancers. But this does not mean that these cancers can be caught like an infection. What happens is that the virus can cause geic changes in cells that make them more likely to bee cancerous. These cancers and viruses are linked Cervical cancer and the genital wart virus, HPV Primary liver cancer and the Hepatitis B virus T cell leukaemia in *** s and the Human T cell leukaemia virus There will be people with primary liver cancer and with T cell leukaemia who haven't had the related virus. But infection may increase their risk of getting that particular cancer. With cervical cancer, scientists now believe that everyone with an invasive cervical cancer will have had an HPV infection beforehand. Many people can be infected with a cancer-causing virus, and never get cancer. The virus only causes cancer in certain situations. Many women get a high risk HPV infection, but never develop cervical cancer. Another example is Epstein-Barr virus (EBV). These are some facts about this mon virus Most people are infected with EBV People who catch it late get glandular fever but this does not cause cancer In sub-Saharan Africa, EBV infection and repeated attacks of malaria together cause a cancer called Burkitt's lymphoma that affects children In China, EBV infection (together with other unknown factors) causes naso-pharyngeal cancer In AIDs patients and transplant patients EBV can cause lymphoma In the UK, about 4 out of 10 cases of Hodgkin's disease seem to be related to EBV infection 可以适当删减
网上投稿很容易的，百度输入投稿，进入一起问道投稿网你就可以看到很多杂志刊物，并且都有提供其联系方式，直接投稿到他们给的邮箱或网站即可。很简单的。
1.找到被投稿方的邮箱地址 2.网上投稿自己一定要有一个好的邮箱，邮箱就是你和编辑联系的最好方式。3.投稿格式：首先，在邮件的主题里面一般要标明：投稿（有的人是提建议啊什么的，这样便于编辑区分！）、投稿的栏目（如果你很熟悉那本杂志，或者那本杂志的征稿讯息很详细，一定要标明栏目，这一点是加印象分的关键！）还有就是作品名称（便于日后编辑找到你的稿子）。以上是最基本的三要素。 然后就是正文了，一般可以加一些问候之类的言语，但不要太多。粘贴文章（注：一般都把自己的文章直接粘贴在正文中，没有特殊要求，不要以附件形式发送。还有，要以简朴为主，不要搞什么信纸啊，插图啊） 最后，在末尾留下你的联系方式，一般采用这个格式（越详细越好）： 真名： 笔名： 地址： 邮编： 邮箱: QQ：
如果是收稿的网站会有投稿地址，或者找编辑进行投稿，当然更简单的方法是找推广公司进行软文代发，和推一手进行过合作，可以自助发稿和软文代发，价格也不高
日常生活中有很多人喜欢在网上写文章，然后进行分享，那么想在投稿客网站投稿该怎么做呢？这里和大家分享一下经验，供大家参考，希望对大家能有所帮助。
以上仅为个人经验，供大家参考。
在英语中，冠词+时间可以代表时间状语,而且像the moment,the minute,the instant这些词还可以引导时间状语从句不过in a minute当然也是可以的 a minute主要还是一个口语化的表达。
光靠投稿，是靠不住的。好文章总是稀缺的，且创作周期较长，而能否兑现稿约、何时兑现稿约都有很大不确定性。所以，唯一的办法就是持续地、广泛地约稿。越是好的刊物，越有维持并提升刊发水准的压力与动力。越是好的期刊，实际上越是会鼓励编辑约稿，而维持并提升刊发水准的基础只有一个：持续不断发好文章。 总体来说，学刊编辑约稿大致可以分为四类：按人约稿、按文索骥、会上邂逅、请人举荐。按人约稿按人约稿是最简单直接的约稿方式，对象往往是资深学者。谁的名气大，就跟谁约。新晋编辑没有稳定的作者队伍和稿源，为了打开工作局面，通常会采用这种广撒网的约稿方式。按文索骥广撒网的约稿方式有其优势，也有其不足：一来，资深学者人数相对较少，而且往往爱惜羽毛轻易不肯赠稿，加上求稿者众，故而成功率较低；二来，也不乏名实不符者，自己约的文章一旦被卡，那真如鲠在喉，吐不出，咽不下，极为尴尬。因此，比较保险的做法是按文索骥。会上邂逅通常来说，学术会议上交流的文章都未公开发表。所以，名刊编辑每年都有固定的开会计划，并且多数是带着约稿任务的。开会约稿还有一个好处：单看文字比较静态，会上交流则更加立体，通过作者的陈述和私下交流，编辑更容易判断文章及作者的深浅轻重。对于作者而言，多开好会是一个更快捷有效的投稿方式，而且在高端学术会议上介绍自己的研究，也可以让学界更充分地认识自己。请人举荐优秀的学刊编辑都很善于利用作者的研究网络，或者请资深作者来主持专栏，或者请他们推荐文章。一般来说，学刊编辑为了组建专栏文章，都会充分吸收相关领域学者的专业意见。
约稿是约请特定的作者撰写某一特定的稿件。首先要物色到最合适的作者和内采用最合适的容组稿方式。约稿时要对作者持平等、热情的态度，明确组稿意图和写作要求，尽量帮助作者解决写稿中的问题和实际困难，对不同的作者采取不同的约稿方法。
约稿主要方式有：统一约稿(征稿启事、信函征稿、座谈会约稿等)、个别约稿(走访、面谈、信约、电话约稿等)。需要注意的是：不能轻率约稿，约到稿件后要尽量采用，要广交朋友，组织一支作者队伍。
扩展资料：
作者具有如下义务：按出版者的要求创作作品；依约定时间交付稿件；不得将所约稿件投寄其他出版者或期刊；稿件交付审读后，若约稿者提出修改意见的，应按约稿者意见修改稿件，并依约交付修改稿。
约稿者有如下义务：稿件收到后在一定时间内通知作者，并于一定时间内审读完毕，通知作者是否采用或退改，约稿者如对稿件无修改意见，在规定的审读期限内与作者签订出版合同；（3)稿件若不符合出版要求，则退交作者修改，并提出修改意见。
约稿，是指报刊或网站编辑邀请特定人士撰写稿件。编辑约稿，一般是根据所在单位的需要，提出稿件主题、叙述方式、作品字数、交稿期限等方面的要求，以便撰稿人把握写作要点，按时提供稿件。被特约供稿的人，多是专家学者、文坛翘楚或者重大历史事件、突发事件的参与者、见证人，比如科学家、防疫专家、探险家、抗战老兵、地震救援队员等。凡是编辑约稿，在合乎要求的情况下，一般都会如期发表，且稿酬从优。
投稿的方法：1、纸质媒体都向外公布常用电子邮箱，可通过邮箱投稿；2、某些报刊杂志开设专门论坛，在论坛上注册并投稿文章，之后编辑会及时审阅并决定是否采用；3、网上搜索要投稿编辑部的信息，查询电子邮箱地址，然后按照地址进行投稿即可。投稿的版权要求：1、所有投稿作品无论是否发表，作者均依照中华人民共和国著作权法享有著作权；2、所有投稿作品投稿期刊及其相关合作机构，包括网站，出版设，移动网络等，享有使用权。
我征稿这段日子，发现还有很多小伙伴不会使用邮箱投稿，所以我特地录了这段用qq邮箱投稿的视频。 视频是直接用手机录制的，如果你们用电脑投稿，原理也是一样的，万变不离其宗。可能有些小伙伴不想看视频，所以我还为你们准备了图文，再学不会，许言也无能为力了。1、打开qq邮箱2、点击右上角的“+”3、点击写邮件4、填写收件邮箱和邮件主题5、添加附件，记住不要把文章放到邮件正文6、选择你要投稿的文章7、再选择图片8、下图就是已经添加成功了9、点击发送，选择原图发送成功之后，就完成投稿了。如果你的身边有不会使用邮箱投稿的小伙伴，你可以给他看这篇文章哦。
在现在自媒体大环境下，利用电子邮件投稿可谓是方便快捷，接下来，就让我来为大家讲讲如何利用电子邮件投稿吧。
电子邮件，电脑或者手机等。
投稿时要备注好自己的联系方式，方便对方编辑联系自己和获得稿费。
易稿平台就很好啊！首先，它会根据自己喜欢的方向设置三个，然后有推荐的，内容丰富，要求清晰，如果是新加入的宝宝，有参考文章供你查阅哦～价格很丰厚，是区间制的，根据你的文章质量来定，个人认为是一个很公正的平台。其次，易稿平台有保存草稿的功能，还可以一键转为正式稿件，这样就不怕丢稿了～最后，易稿平台是有审稿时间的，大概在三天，审核通过后可以把钱提到微信中哦～当然也不会让你等很久，如果你喜欢写文章就加入到易稿来吧～
你是要自己做活动，微信可以选自带小程序，如果想更灵活可以选择第三方的，例如 光明云投你要是想投稿赚钱，还是要细分领域。可以知乎看看有没有人推荐
文章投稿平台有简书、壹写作、期刊杂志投稿网、汤圆创作、网易蜗牛读书、稿源网、卓芒文学网、篇海文学网、爱投稿网、小荷作文网等。简书。简书是一个创作社区，是简书的创作者们的作品管理工具，用户在简书上面可以方便的创作自己的作品，互相交流，简书成为国内优质原创内容输出平台，为用户推荐热门的专题、创作者，帮助用户发现新的热门专题。壹写作。壹写作是一款免费写作软件、写小说、写剧本、网络写手的写作软件，手机写作、电脑写作、mac写作软件同步写作，长篇连载的写小说，复杂的剧本创作，在任何时间，通过任何设备轻松同步用户写作的灵感。
稿稿平台是一个新媒体稿件交易平台，简单说，就是新媒体平台运营者发布稿件需求，平台注册用户根据要求写稿投稿，被采纳能获得稿费（注：稿费30%属于平台服务费，新手应该注意）。如你猜测的那样，卖稿，就是把使用权（署名权、修改权、编辑权）卖出去，如果不放心可以选择用其他方式去变现。稿件交易，实际上是知识付费的一种，题主的文笔好、写作热情高，可以在知乎和公众号等地方坚持输出内容。积累了一定的粉丝量之后，可以考虑做知识付费。